CLU and prostate cancer: Conversely, promoter demethylation experiments conducted in prostate cancer cells [45], endothelial cells [78] and retinal pigment epithelial cells [79] using epigenetic drugs significantly increased CLU gene transcription in these cells (Figure 4).